Business
Regen BioPharma, Inc. Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB)
Regen BioPharma, Inc. Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB).
About this update from Regen Biopharma, Inc.
[{"type":"text","content":"\n\n\n\nRegen BioPharma, Inc. Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB)\n\n\n\n\n\nRegen BioPharma, Inc. Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB)\nCVS Health, Inc. Director Jean-Pierre Millon will serve as Chairman of the BAB, Roger Formisano and Robert Hopkins to serve as BAB board members for Regen BioPharma Inc.\nPR Newswire\nSAN DIEGO, October 30, 2017\n\n\n\nSAN DIEGO, October 30, 2017 /PRNewswire/ --\n\nRegen BioPharma, Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) announced that former Eli Lilly executive Jean-Pierre Millon will serve as chairman of its newly formed business advisory board (BAB). The Company also announced that two esteemed life science and healthcare executives have agreed to serve as members of the BAB. The advisory board will assist Regen's management team in evaluating partnership and licensing opportunities related to the company's intellectual property including its NR2F6 program.\n\n\"We are pleased to have such a highly accomplished and respected group of individuals join our advisory board,\" said Todd Caven, CFO at Regen BioPharma. \"Their collective insight and expertise will be extremely helpful to the executive team as we evaluate various opportunities with respect to our intellectual property portfolio in 2018 and beyond.\" \n\nThe initial members of the board are as follows:\n\nJean-Pierre Millon (Chairman) is a director at CVS Health, Inc. [NYSE:CVS]. His board position evolved after a CVS merger with Caremark in April 2007 and Caremark's purchase of AdvancePCS, a pharmacy benefit management company, in 2004. Before his post with Caremark, Mr. Millon was named to the board of AdvancePCS in 2000 upon the merger of Advance Paradigm and PCS Health Systems. He was president and chief executive officer of PCS from 1996 to 2000. Prior to joining PCS, Mr. Millon was an executive with Eli Lilly and Company. His career with Lilly and its subsidiaries spanned two decades and was highlighted by leadership positions in the United States and executive posts in Asia, Europe and the Caribbean Basin. A native of Paris, Mr. Millon is fluent in French, English, German and Spanish.\n\nRoger Formisano, PhD (board member) is Vice-President for Leadership and St...